- Home
- MFM vs DRTS Comparison
MFM vs DRTS Comparison
Compare MFM & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFM
- DRTS
- Stock Information
- Founded
- MFM 1986
- DRTS 2015
- Country
- MFM United States
- DRTS Israel
- Employees
- MFM N/A
- DRTS N/A
- Industry
- MFM Finance Companies
- DRTS Medical/Dental Instruments
- Sector
- MFM Finance
- DRTS Health Care
- Exchange
- MFM Nasdaq
- DRTS Nasdaq
- Market Cap
- MFM 212.1M
- DRTS 252.8M
- IPO Year
- MFM N/A
- DRTS N/A
- Fundamental
- Price
- MFM $5.10
- DRTS $3.08
- Analyst Decision
- MFM
- DRTS Strong Buy
- Analyst Count
- MFM 0
- DRTS 2
- Target Price
- MFM N/A
- DRTS $8.00
- AVG Volume (30 Days)
- MFM 108.1K
- DRTS 36.5K
- Earning Date
- MFM 01-01-0001
- DRTS 08-13-2025
- Dividend Yield
- MFM 4.08%
- DRTS N/A
- EPS Growth
- MFM N/A
- DRTS N/A
- EPS
- MFM 0.03
- DRTS N/A
- Revenue
- MFM N/A
- DRTS N/A
- Revenue This Year
- MFM N/A
- DRTS N/A
- Revenue Next Year
- MFM N/A
- DRTS N/A
- P/E Ratio
- MFM $176.67
- DRTS N/A
- Revenue Growth
- MFM N/A
- DRTS N/A
- 52 Week Low
- MFM $4.37
- DRTS $1.93
- 52 Week High
- MFM $5.48
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- MFM 48.92
- DRTS 59.10
- Support Level
- MFM $5.14
- DRTS $3.12
- Resistance Level
- MFM $5.23
- DRTS $3.35
- Average True Range (ATR)
- MFM 0.05
- DRTS 0.15
- MACD
- MFM 0.00
- DRTS 0.02
- Stochastic Oscillator
- MFM 46.67
- DRTS 70.00
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.